Noctrix Health
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Noctrix Health sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Noctrix Health: 8 sponsored US clinical trials, 1 recruiting.
Noctrix Health sponsors 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Restless Legs Syndrome, with 4 trials.
Upper-quartile sponsor footprint
Noctrix Health sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)
NCT07675109
Response to an Investigational Device in Patients With Restless Legs Syndrome
NCT06866132
A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS
NCT06076499
Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS
NCT05214963
Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS
NCT05196828
Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)
NCT04874155
Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction
NCT04698343
Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome
NCT04700683
Therapeutic Areas
What is open in the Noctrix Health pipeline
1 recruiting of 8 indexed (13% open); 5 completed (63%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Restless Legs Syndrome (4 trials), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Noctrix Health: open-pipeline peers nationwide
Peers matched on 8 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Noctrix Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this Noctrix Health page
8 registered trials is a research-attention snapshot, not an endorsement of Noctrix Health or any single study.
- 1 of Noctrix Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Restless Legs Syndrome is the condition Noctrix Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Restless Legs Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Noctrix Health pipeline card: 8 registered trials from official public datasets.Report a data error.